CECO’s (NASDAQ:CECO) Q4 Sales Beat Estimates, Guides for Strong Full-Year Sales
Air quality and fluid handling company CECO (NASDAQ:CECO) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 3.2% year on year to $158.6 million. The company’s full-year revenue guidance of $725 million at the midpoint came in 4.1% above analysts’ estimates. Its non-GAAP profit of $0.27 per share was 19.1% above analysts’ consensus estimates.
LGI Homes (NASDAQ:LGIH) Misses Q4 Revenue Estimates
Affordable single-family home construction company LGI Homes (NASDAQ:LGIH) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 8.4% year on year to $557.4 million. Its GAAP profit of $2.15 per share was in line with analysts’ consensus estimates.
Keurig Dr Pepper (NASDAQ:KDP) Beats Q4 Sales Targets
Beverage company Keurig Dr Pepper (NASDAQ:KDP) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 5.2% year on year to $4.07 billion. Its non-GAAP profit of $0.58 per share was in line with analysts’ consensus estimates.
DigitalOcean (NYSE:DOCN) Beats Q4 Sales Targets, Stock Jumps 18.3%
Cloud computing provider DigitalOcean (NYSE: DOCN) announced better-than-expected revenue in Q4 CY2024, with sales up 13.3% year on year to $204.9 million. The company expects next quarter’s revenue to be around $208 million, close to analysts’ estimates. Its non-GAAP profit of $0.49 per share was 43.7% above analysts’ consensus estimates.
Shoals’s (NASDAQ:SHLS) Q4 Sales Top Estimates But Stock Drops
Solar energy systems company Shoals (NASDAQ:SHLS) announced better-than-expected revenue in Q4 CY2024, but sales fell by 18% year on year to $107 million. On the other hand, next quarter’s revenue guidance of $75 million was less impressive, coming in 25% below analysts’ estimates. Its non-GAAP profit of $0.08 per share was 16.7% below analysts’ consensus estimates.
AdaptHealth (NASDAQ:AHCO) Posts Better-Than-Expected Sales In Q4, Stock Soars
Healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales were flat year on year at $856.6 million. On the other hand, the company’s full-year revenue guidance of $3.29 billion at the midpoint came in 1.2% below analysts’ estimates. Its GAAP profit of $0.34 per share was 34.8% above analysts’ consensus estimates.
Middleby (NASDAQ:MIDD) Exceeds Q4 Expectations
Kitchen product manufacturer Middleby (NYSE:MIDD) announced better-than-expected revenue in Q4 CY2024, but sales were flat year on year at $1.01 billion. Its non-GAAP profit of $2.88 per share was 14.2% above analysts’ consensus estimates.
Novanta (NASDAQ:NOVT) Misses Q4 Sales Targets
Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 12.5% year on year to $238.1 million. Next quarter’s revenue guidance of $234 million underwhelmed, coming in 4.4% below analysts’ estimates. Its non-GAAP profit of $0.76 per share was 6.5% above analysts’ consensus estimates.